XML 422 R95.htm IDEA: XBRL DOCUMENT
v3.26.1

Financial instruments - Other long-term investments (Details) - EUR (€) € in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2025 | Dec. 31, 2024
Investments other than equity method investments |  |
Balance at January 1 | € 34,370 | € 135,593
Additions | 10,893 | 7,532
Reclassified as Held for Sale | (3,830) |
Disposals | (1,918) | (69,370)
Fair value adjustments recognized in profit or loss | 4,269 | (34,310)
Adjustments to fair value, recognized in OCI | (1,144) | (5,075)
Balance at December 31 | 42,640 | 34,370
Tubulis GmbH, Munich, Germany |  |
Investments other than equity method investments |  |
Additions | 3,634 | 1,116
Fair value adjustments recognized in profit or loss | 1,597 | 4,314
Aurobac Therapeutics SAS, Lyon, France |  |
Investments other than equity method investments |  |
Additions | 2,500 |
Mission BioCapital V LP, Cambridge, United States |  |
Investments other than equity method investments |  |
Additions | 1,802 | 1,390
Curie Bio Seed Fund I LP, Boston, USA |  |
Investments other than equity method investments |  |
Additions | 1,287 | 2,214
Fair value adjustments recognized in profit or loss | (1,140) | 1,518
Aeovian Pharmaceuticals Inc., San Francisco, United States |  |
Investments other than equity method investments |  |
Reclassified as Held for Sale | (3,830) |
Fair value adjustments recognized in profit or loss | 3,500 | (3,866)
Recursion Pharmaceuticals Inc. |  |
Investments other than equity method investments |  |
Disposals |  | (69,370)
Sernova Corp. |  |
Investments other than equity method investments |  |
Adjustments to fair value, recognized in OCI | € (1,144) | € (5,075)

X
- Definition Decrease in investments other than equity method investments resulting from disposals. + References No definition available. + Details
Name: | evo_DecreaseInInvestmentsOtherThanEquityMethodInvestmentsResultingFromDisposals
Namespace Prefix: | evo_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table. + References No definition available. + Details
Name: | evo_DisclosureOfInvestmentsAccountedForOtherThanEquityMethodInvestmentsLineItems
Namespace Prefix: | evo_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Increase decrease in investment other than investments accounted for using equity method adjustments to fair value not affecting income. + References No definition available. + Details
Name: | evo_IncreaseDecreaseInInvestmentOtherThanInvestmentsAccountedForUsingEquityMethodAdjustmentsToFairValueNotAffectingIncome
Namespace Prefix: | evo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of increase (decrease) in investment other than investments accounted for using equity method due to fair value adjustments, affecting net income + References No definition available. + Details
Name: | evo_IncreaseDecreaseInInvestmentOtherThanInvestmentsAccountedForUsingEquityMethodDueToFairValueAdjustmentsRecognizedProfitOrLoss
Namespace Prefix: | evo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of increase (decrease) in investment other than investments accounted for using equity method due to reclassifications into assets held for sale. + References No definition available. + Details
Name: | evo_IncreaseDecreaseInInvestmentsOtherThanEquityMethodInvestmentsResultingFromClassificationsAsHeldForSale
Namespace Prefix: | evo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Increase in investments other than equity method investments resulting from additions. + References No definition available. + Details
Name: | evo_IncreaseInInvestmentsOtherThanEquityMethodInvestmentsResultingFromAdditions
Namespace Prefix: | evo_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of non-current investments other than investments accounted for using the equity method. [Refer: Investments accounted for using equity method; Non-current assets; Investments other than investments accounted for using equity method] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 55 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_NoncurrentInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | evo_OtherInvestmentAxis=evo_TubulisGmbhMunichGermanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | evo_OtherInvestmentAxis=evo_AurobacTherapeuticsSasLyonFranceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | evo_OtherInvestmentAxis=evo_MissionBiocapitalVLpCambridgeUsaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | evo_OtherInvestmentAxis=evo_CurieBioSeedFundIL.p.BostonUsaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | evo_OtherInvestmentAxis=evo_AeovianPharmaceuticalsInc.SanFranciscoUsaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | evo_OtherInvestmentAxis=evo_RecursionPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | evo_OtherInvestmentAxis=evo_SernovaCorpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |